Ovarian cancer
Results
Phase 3
This trial looked at giving farletuzumab alongside chemotherapy for ovarian cancer that had come back after platinum chemotherapy.
Recruitment start: 1 April 2009
Recruitment end: 29 February 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nicholas Reed
Eisai
Experimental Cancer Medicine Centre (ECMC)
Morphotek
Last reviewed: 03 Oct 2016
CRUK internal database number: 6322
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
